Granting affordable access to medicines by developing and producing generic pharmaceuticals has always been a cornerstone of Unipharm Ltd., Israel’s vision. In 2017 Unipharm Ltd., Israel opened its new EU-GMP compliant state-of-the-art manufacturing facility in Mavo Carmel, Israel. This facility is built with the newest technologies in pharma manufacturing, allowing increased production efficiency and cost savings. Unipharm Ltd., Israel is expanding its export activities to Europe, while reaching additional International Markets.
Unipharm was founded in 1975 in Israel and since its early days has been a dominant player in the generic pharmaceutical arena in Israel. Unipharm’s new oral solid manufacturing plant in Israel is of high production capabilities and is EU GMP certified.
Israel is Addicted to Imports, Says President of Israeli Manufacturers Association
Unipharm’s co-CEO, Dr. Ron Tomer, was elected president of the Manufacturers Association of Israel
on January 30 th , 2020.
Dr. Ron Tomer (53) received his bachelor’s degree in Pharmacy in 1991 from the School of Pharmacy
at the Hebrew University of Jerusalem. He then went on to pursue his PhD research at the School of
Pharmacy at the University of London, which he completed in 1994. Dr. Tomer also holds an MBA
from the Recanati School of Business at the Tel Aviv University.
Son of Zvulun Tomer (83), founder of Unipharm, a leading Israeli generic pharmaceutical company,
Ron joined his parents in the family business in 1995. Since then, Ron has contributed to Unipharm’s
growth significantly, transforming it from a small company to one of Israel's largest generic
pharmaceutical companies and a drug supplier to hundreds of thousands of Israeli citizens. In 2017
Unipharm opened its new EU-GMP compliant state-of-the-art manufacturing facility in Mavo
Carmel, Israel. This facility is built with the newest technologies in pharma manufacturing, allowing
increased production efficiency and cost savings. Unipharm Mavo Carmel is now starting to export
its many generic products to Europe, while expanding to additional International Markets.
During the last 11 years, Ron has been very active with the Manufacturers Association of Israel,
chairing its “Made in Israel” committee and its Committee of Economy and Regulation.
Unipharm Ltd. Israel is proud of Ron’s achievement and we all wish him the best of luck in advancing
the Israeli Industries and supporting the Israeli Manufacturers in the years to come.
An interview with Unipharm’s VP, Dr. Ron Tomer, about the opening of Unipharm Mavo Carmel, Israel’s newest oral solid pharmaceutical manufacturing plant, which is expected to supply high quality generics to many international markets.